Clinical Trials Directory

Trials / Completed

CompletedNCT01150279

Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up

Simplifying Medical Abortion Provision: Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up

Status
Completed
Phase
Study type
Observational
Enrollment
1,200 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will examine the feasibility, acceptability and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) for at-home follow-up after early medical abortion using mifepristone+misoprostol. The study seeks to: 1. Assess the feasibility of using this test in lieu of standard one-week clinic-based follow up for determination of complete abortion status as part of normal service delivery. In Mexico, follow up will be in two weeks, as is standard care in that . 2. To determine if women using this test at home understand how to use it and can correctly interpret the results; is it practical. 3. Assess women's and provider's acceptability of using at-home pregnancy tests in lieu of clinic-based follow up for confirmation of complete medical abortion in the future.

Conditions

Timeline

Start date
2009-08-01
Primary completion
2014-05-01
First posted
2010-06-24
Last updated
2015-10-02

Locations

11 sites across 4 countries: United States, Mexico, Tunisia, Vietnam

Source: ClinicalTrials.gov record NCT01150279. Inclusion in this directory is not an endorsement.

Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-up (NCT01150279) · Clinical Trials Directory